Back
EMCOR Group Vs. Novo Nordisk AS Industry Stock Comparison
Sell
47
EME
EMCOR Group
Last Price:
$463.75
Seasonality Move:
6.34%
Sell
18
NONOF
Novo Nordisk AS
Last Price:
$87.75
Seasonality Move:
6.72%
Sell
47
EMCOR Group (EME)
is a Sell
Is EMCOR Group a Buy, Sell or Hold?
-
The current EMCOR Group [EME] share price is $463.26. The Score for EME is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
EME is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.86. The Score for NONOF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EME Stock Price Chart
What is EMCOR Group's stock price today?
-
The EMCOR Group share price today is $463.26Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EME is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.86Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
EME Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.29 | Sell |
Relative Strength Index (14 RSI): | 37.17 | Sell |
Chaikin Money Flow: | 103459 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (475.08 - 514.6) | Sell |
Bollinger Bands (100): | (381.66 - 490.32) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.61 | Sell |
Relative Strength Index (14 RSI): | 29.63 | Sell |
Chaikin Money Flow: | -16178 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.97 - 111.89) | Sell |
Bollinger Bands (100): | (106.42 - 130.98) | Sell |
EME Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 472.35 | Sell |
20-day SMA: | 490.42 | Sell |
50-day SMA: | 480.64 | Sell |
200-day SMA: | 399.8 | Buy |
8-day EMA: | 471.9 | Sell |
20-day EMA: | 482.34 | Sell |
50-day EMA: | 474.17 | Sell |
200-day EMA: | 398.63 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.02 | Sell |
20-day SMA: | 106 | Sell |
50-day SMA: | 108.66 | Sell |
200-day SMA: | 125.92 | Sell |
8-day EMA: | 98.92 | Sell |
20-day EMA: | 103.95 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.71 | Sell |
EMCOR Group Earnings Growth & EME Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.54 per share, and an increase next year of $1.74 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
EMCOR Group Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |